ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,522.40
      1.05%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,840.73
      -0.11%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC

      6. BioNxt Solutions Inc (QB) (BNXTF) Quote

      BioNxt Solutions Inc (QB)

      BioNxt Solutions Inc (QB) (BNXTF)

      USOTC
      0.20916
      0.00
      (0.00%)
      Closed July 26 4:00PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      0.20916
      Bid
      0.1116
      Ask
      0.32
      Volume
      -
      0.00 Day's Range 0.00
      0.002 52 Week Range 0.5656
      Market Cap
      23.116M
      Previous Close
      0.20916
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      1,666
      Shares Outstanding
      110,519,065
      Dividend Yield
      -
      PE Ratio
      -2.58
      Earnings Per Share (EPS)
      -0.07
      Revenue
      372k
      Net Profit
      -7.72M

      About BioNxt Solutions Inc (QB)

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.bionxt.com
      Headquarters
      Vancouver, British Columbia, Can
      Founded
      1970
      BioNxt Solutions Inc (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker BNXTF. The last closing price for BioNxt Solutions (QB) was $0.21. Over the last year, BioNxt Solutions (QB) shares have traded in a share price range of $ 0.002 to $ 0.5656.

      BioNxt Solutions (QB) currently has 110,519,065 shares outstanding. The market capitalization of BioNxt Solutions (QB) is $23.12 million. BioNxt Solutions (QB) has a price to earnings ratio (PE ratio) of -2.58.

      BNXTF Latest News

      More News
      No news to show yet.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.001880.9069857197990.207280.209160.123227100.20737365CS
      4-0.01638-7.26256983240.225540.2780.123212270.22682908CS
      12-0.07254-25.7507987220.28170.30.123216660.24428616CS
      26-0.19084-47.710.40.51010.123214890.31355929CS
      52-0.12319-37.06634571990.332350.56560.00220320.28314878CS
      156-0.08084-27.8758620690.290.581040.001420530.33381167CS
      260-0.08084-27.8758620690.290.581040.001420530.33381167CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      WINTWindtree Therapeutics Inc
      $ 8.24
      (150.46%)
      		48.57M
      BFIBurgerFi International Inc
      $ 0.4206
      (97.37%)
      		313.59M
      NBSTWNewbury Street Acquisition Corporation
      $ 0.1349
      (92.71%)
      		122.1k
      YIBOPlanet Image International Ltd
      $ 2.915
      (53.43%)
      		260.07k
      CREVCarbon Revolution Public Ltd
      $ 9.00
      (45.87%)
      		8.06M
      NMHINatures Miracle Holding Inc
      $ 0.2035
      (-48.06%)
      		7.69M
      TANHTantech Holdings Ltd
      $ 0.2585
      (-47.23%)
      		6.75M
      DXCMDexCom Inc
      $ 64.00
      (-40.66%)
      		53.92M
      PSIGPS International Group Ltd
      $ 1.42
      (-31.40%)
      		716.26k
      POAIPredictive Oncology Inc
      $ 1.36
      (-27.27%)
      		6.02M
      SLNASelina Hospitality PLC
      $ 0.0305
      (-18.88%)
      		408.61M
      BFIBurgerFi International Inc
      $ 0.4206
      (97.37%)
      		313.59M
      NVDANVIDIA Corporation
      $ 113.06
      (0.69%)
      		293.33M
      SQQQProShares UltraPro Short QQQ
      $ 9.10
      (-2.88%)
      		176.49M
      SGMOSangamo Therapeutics Inc
      $ 0.8612
      (28.15%)
      		123.71M

      BNXTF Discussion

      View Posts
      Renee Renee 2 years ago
      XPHYF changed to BNXTF:

      https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
      👍️0
      Renee Renee 2 years ago
      XPHYF: effective Nov. 14,2022 XPhyto Therapeutics Corp. will change to Bionxt Solutions Inc.:

      https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
      👍️0
      jonner jonner 3 years ago
      https://www.marketbeat.com/stocks/OTCMKTS/XPHYF/news/
      👍️0
      jonner jonner 3 years ago
      https://www.finanznachrichten.de/nachrichten-2021-07/53523533-xphyto-therapeutics-corp-xphyto-s-acquisition-target-3a-diagnostics-reports-breakthrough-identification-of-covid-19-biosensor-candidates-200.htm
      👍️0
      jonner jonner 3 years ago
      These tests will certainly become useful during international travel
      👍️0
      jonner jonner 3 years ago
      👍️0
      jonner jonner 3 years ago
      https://www.mmjreporter.com/3-big-biotech-disruptors-for-2021-41311?utm_source=interactiveoffers&utm_medium=email&utm_campaign=14226&utm_term=elitetrade.club&utm_content=29235&c=0&h=1&ax_09Am1=g6f6A&iocid=048b2c33aa22226728dbfe6c15db87241c7ababf
      👍️0
      jonner jonner 3 years ago
      https://finance.yahoo.com/quote/XPHYF?p=XPHYF&.tsrc=fin-srch
      👍️0
      jonner jonner 3 years ago
      https://www.globenewswire.com/news-release/2021/03/12/2192089/0/en/InvestorBrandNetwork-IBN-Announces-Latest-Episode-of-The-Bell2Bell-Podcast-featuring-Hugh-Rogers-CEO-and-Director-of-XPhyto-Therapeutics-Corp.html
      👍️0
      jonner jonner 3 years ago
      $XPHYF
      👍️0
      jonner jonner 3 years ago
      Hi everyone. I set this board up.
      👍️0

      Your Recent History

      USOTC
      BNXTF
      BioNxt Solutions (QB)
      Delayed Upgrade Clock